Publication | Closed Access
Nationwide Experience With Off‐Label Use of Interleukin‐1 Targeting Treatment in Familial Mediterranean Fever Patients
60
Citations
15
References
2017
Year
Anti-IL-1 treatment is an effective alternative for controlling attacks and decreasing proteinuria in colchicine-resistant FMF patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1